| NCT ID | NCT02308020 |
| Title | A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications |
Her2-receptor positive breast cancer Her2-receptor negative breast cancer |
| Therapies | |
| Age Groups: | senior adult |